91 studies found for:    (celiac disease) [CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Recruiting Detection of Celiac Disease in Patients With Hypothyroidism
Conditions: Celiac Disease;   Hypothyroidism;   Celiac Sprue;   Malabsorption
2 Recruiting Antibody Treatment for Advanced Celiac Disease
Conditions: Celiac Disease;   Celiac Sprue;   Gluten Enteropathy;   Gluten-Sensitive Enteropathy
Intervention: Biological: Hu-Mik- Beta-1
3 Completed Evaluation of Patient Reported Outcome Instruments in Celiac Disease Patients
Condition: Celiac Disease
4 Completed Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Biological: ALV003;   Biological: ALV003 placebo
5 Completed Safety and Efficacy of ALV003 for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Biological: ALV003;   Biological: ALV003 placebo
6 Recruiting Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients
Condition: Celiac Disease
Interventions: Drug: ALV003;   Drug: placebo
7 Completed HLA-DQ2-gliadin Tetramer for Diagnosis of Celiac Disease
Conditions: Celiac Disease;   Gluten
Intervention: Dietary Supplement: Gluten challenge.
8 Enrolling by invitation Immune Response in Celiac Disease on In-vitro Gluten Challenge
Condition: Celiac Disease
9 Completed Safety Study of Nexvax2 in Subjects With Coeliac Disease
Conditions: Coeliac Disease;   Celiac Disease
Interventions: Biological: 9 micrograms Nexvax2;   Biological: 30 micrograms Nexvax2;   Biological: 90 micrograms Nexvax2;   Biological: 60 micrograms Nexvax2;   Biological: Up to 900 micrograms Nexvax2;   Other: Placebo
10 Completed A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
Condition: Celiac Disease
Interventions: Drug: Larazotide Acetate 0.5 mg;   Drug: Larazotide Acetate 1 mg;   Drug: Larazotide Acetate 2 mg;   Drug: placebo
11 Recruiting Screen-detected Coeliac Disease, a Population Based Study
Condition: Celiac Disease
Intervention: Other: Gluten-free diet
12 Completed Effect of Aspergillus Niger Prolyl Endoprotease (AN-PEP) Enzyme on the Effects of Gluten Ingestion in Patients With Coeliac Disease
Condition: Celiac Disease
Interventions: Dietary Supplement: Aspergillus niger prolyl endoprotease;   Dietary Supplement: Placebo
13 Not yet recruiting Celiac Disease and Unexplained Iron Deficiency in a Primary Care Setting
Conditions: Celiac Disease;   Iron Deficiency;   Iron Malabsorption
14 Active, not recruiting Gluten-free Diet in Gluten-genetically Predisposed Subjects
Conditions: Genetic Predisposition to Disease;   Celiac Disease
Intervention: Dietary Supplement: Gluten-free diet
15 Completed Performance Evaluation of Capsule Endoscopy in the Diagnosis of Gluten Sensitive Enteropathy (MA-23)
Condition: Celiac Disease
Intervention: Device: Capsule Endoscopy
16 Completed Treatment of Mild Enteropathy Celiac Disease
Condition: Celiac Disease
Intervention: Dietary Supplement: Gluten-free diet
17 Completed Gut Peptides and Intestinal Permeability in Celiac Disease and Irritable Bowel Syndrome
Conditions: Celiac Disease;   Irritable Bowel Syndrome
18 Recruiting Celiac Disease and Diabetes- Dietary Intervention and Evaluation Trial
Conditions: Celiac Disease;   Diabetes Mellitus, Type 1
Intervention: Dietary Supplement: Gluten Free Diet
19 Terminated Response to Hepatitis B Vaccine in Celiac Disease Patients
Condition: Celiac Disease
Intervention: Biological: hepatitis B vaccine (EngerixB)
20 Unknown  Study of Enzyme Supplements to Treat Celiac Disease
Conditions: Celiac Disease;   Dermatitis Herpetiformis
Interventions: Drug: STAN1;   Drug: Placebo enzyme;   Drug: STAN1+gluten

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years